Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
Journal of Human Genetics|July 8, 2011
A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese malesChanavee Ratanajaraya, Hiroyuki Nishiyama, Meiko Takahashi, et al.
Cancer Genomics & Proteomics|December 27, 2023
CXCL10 Expression in Human Colorectal Cancer Tissue and its Correlation With Serum Levels of CXCL10Lianbo Li, Kosuke Kanemitsu, Koji Ohnishi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor]Takahisa Nakamura, Jun-Ichirou Yasunaga, Kiho Yokoo, et al.
Neuroradiology|February 11, 2014
Quantitative imaging values of CT, MR, and FDG-PET to differentiate pineal parenchymal tumors and germinomas: are they useful?Takahide Kakigi, Tomohisa Okada, Mitsunori Kanagaki, et al.
Virchows Archiv : an International Journal of Pathology|March 20, 2025
Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancerRin Yamada, Kota Arima, Hiromu Yano, et al.
Cancer Science|May 19, 2011
Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patientsNiansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|December 21, 2025
Posterior Fossa Group A Ependymoma in Trisomy 21Yuta Fujimoto, Hirotaka Inoue, Jun-Ichiro Kuroda, et al.
Scandinavian Journal of Gastroenterology|May 10, 2017
Multicystic biliary hamartoma with extremely elevated CA19-9: a case reportTakeshi Morinaga, Katsunori Imai, Yo-Ichi Yamashita, et al.
Human Pathology|April 24, 2009
High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease?Aya Miyagawa-Hayashino, Yumi Matsumura, Fumi Kawakami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide]Hiroshi Yoshibayashi, Hiroshi Ishiguro, Masahiro Takada, et al.
Pageof 21